Consistent with results obtained for ovarian cancer and acute myeloid leukemia, our study of glioma revealed that VMP1 overexpression is related to disease progression and a poor prognosis, and VMP1 KO inhibits cell proliferation and induces cell death. Here, VMP1 is linked to central nervous system cancer.